CDKN2A and neoplasm: These include tumors from women that carried the minor allele of the rs11515 polymorphism in the 3′ UTR of cyclin dependent kinase inhibitor 2A (CDKN2A) that encodes both the p16INK4a and p14ARF tumor suppressors (13).